Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06057480 · ClinicalTrials.gov registry record · NA

APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs

A NA study, sponsored by Saluda Medical Pty.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT06057480 is a NA study that has completed, run by Saluda Medical Pty. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06057480, a NA study, has completed, sponsored by Saluda Medical Pty.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Study to evaluate the use of the Assisted Programming Module (APM) in the Evoke Spinal Cord Stimulation (SCS) System to program patients with chronic pain of the trunk and/or limbs.

Interventions

  • DEVICE APM

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-09-26
Est. Completion 2024-12-19
Phase NA

Sponsor

Saluda Medical Pty

4 total trials

What the Registry Record Tells You About NCT06057480

The ClinicalTrials.gov registry entry for NCT06057480 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saluda Medical Pty, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which APM is the first listed.

NCT06057480 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06057480 about?

NCT06057480 is a clinical study titled "APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs". Study to evaluate the use of the Assisted Programming Module (APM) in the Evoke Spinal Cord Stimulation (SCS) System to program patients with chronic pain of the trunk and/or limbs.

What is the current status of trial NCT06057480?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-09-26. Estimated completion is 2024-12-19.

What interventions are being tested in trial NCT06057480?

The interventions under investigation include: APM (DEVICE).

Who is sponsoring clinical trial NCT06057480?

This trial is sponsored by Saluda Medical Pty, which has 4 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.